Stimulant Still Available for Sale Despite FDA Action

DMAA marketed as a dietary supplement

WEDNESDAY, Dec. 5 (HealthDay News) -- Products containing 1,3-dimethylamylamine (DMAA), a stimulant marketed as a dietary supplement in the United States, are still available for sale despite a warning from the U.S. Food and Drug Administration, according to a research letter published online Dec. 3 in the Archives of Internal Medicine.

Philip J. Gregory, Pharm.D., from Creighton University in Omaha, Neb., surveyed whether 16 products containing DMAA were available for sale through online retailers as of May 17, 2012. The FDA had sent warning letters to the manufacturers of these products on April 27, 2012, stating that the products were considered adulterated because DMAA is considered a new dietary ingredient. A manufacturer of a new dietary ingredient is required to submit documentation demonstrating the expectation of safety; if this documentation is not received, the FDA considers the product to be an unapproved drug.

Gregory found that all 16 products were still available for sale, either through online retailers or directly from the manufacturer. None of the Web sites noted that the products were illegal, adulterated, and generally not permitted for sale.

"Despite this warning, all of the products in question are still readily available," Gregory concludes. "This suggests that the FDA's warning process may do little to nothing to stem the significant public health risk posed by this potentially dangerous ingredient."

Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events